ECG
Everus Construction Group Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
BEAT - a growth story just getting started (FDA approved)
Up 100 percent YTD, First Time Above the 200MA in Years, and the Last Time This Happened It Ran 300% - ThreeD Capital (CSE: IDK / OTCQX: IDKFF)
ThreeD Capital (CSE: IDK / OTCQX: IDKFF) - Up 100 percent YTD, First Time Above the 200MA in Years, and the Last Time This Happened It Ran 300%
ThreeD Capital (CSE: IDK / OTCQX: IDKFF) - Up 100 percent YTD, First Time Above the 200MA in Years, and the Last Time This Happened It Ran 300%
ThreeD Capital (CSE: IDK / OTCQX: IDKFF) - Buying $0.27 of audited assets for $0.08, run by the guy who turned $0.10 into $26.00
$IDKFF | ThreeD Capital – Buying $1 of Assets for ~20¢, 51-Company Portfolio, Now Back Above 200-Day MA for First Time in Years
$IDKFF | ThreeD Capital – Buying $1 of Assets for ~20¢, 51-Company Portfolio, Now Back Above 200-Day MA for First Time in Years
AIML ...What the Latest Report Is Pointing To
Intelimed and Neural Cloud: a Latin American bet on smarter ECG and arrhythmia detection
AIML Innovations Expands Neural Cloud Into Latin America Through Intelimed Partnership
AIML Innovations Expands Neural Cloud Into Latin America Through Intelimed Partnership
Jamaica to Latin America ... AIML’s Growth Strategy Is Taking Shape
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
Neural Cloud Expands Into Latin America With New Distribution Agreement
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
AIML’s commercial puzzle is starting to come together
AIML: NeuralCloud Expands Bundled ECG Solutions Through Strategic Collaboration with Movesense
Been thinking about adding more AIML.....Would love some advices.
Been thinking about adding more AIML.....Would love some thoughts.
The Economic of ECG Evaluation: From Volume to Value
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
AI/ML Innovations Inc. (AIML | CSE: AIML | OTCQB: AIMLF | FSE: 42FB): Where AI and Digital Health Meet
Compelling MedTech Presenting Asymetric Returns (DeepDive)
AI/ML Innovations Inc. (AIML | CSE: AIML | OTCQB: AIMLF | FSE: 42FB): Where AI and Digital Health Meet
ROYAL GAMBLE BETS ($SRXH, $BEAT, and $VMAR)
BEAT received FDA approval yesterday
European markets when the US has a day off… 😂 📉
Investing in HeartBeam ($BEAT): Bringing Clinic-Grade ECGs into Patients’ Pockets ❤️
Watchlist For the Rest of the Week: Screener Picked Some Things Up
$BEAT - First patent significantly advances intellectual property for HeartBeam’s credit card-sized ECG device, bolstering both the defensive and offensive moat around the company’s core technology
$BEAT - HeartBeam’s patented 3D ECG technology captures the heart’s electrical signals in 3 non-coplanar directions and then synthesizes these signals into a 12-lead ECG using a personalized transformation matrix.
$BEAT big news this week: HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
Global markets are the new cryptocurrency
Mentions
They do have competition, their competitors have similar devices but without the robust detail that you can normally only get from an ECG at a hospital with electrodes attached to you. They've got an insane patent moat around their algo, hardware, and concepts, but the 12-lead synthetic ECG is the most important part. Having that in a device or smart watch that can give you a hospital accurate reading, where you can also have those readings checked in real time by a doctor 24/7 (this is a currently being tested), and can even warn if you're about to have a heart attack is insanely valuable. Having that validated by this study and getting approval from the FDA for a larger, clinical study in the US would make them ripe for acquisition if successful. Do some research if you're interested
BEAT. 12-lead synthetic ECG (no electrodes needed) that can detect more than just the simple arrhythmia your apple and Samsung watches can. It can detect not only more complex arrhythmias, but even detect if you're at risk of an imminent heart attack. And again, synthetic 12-lead ECG. That's huge, that's the most accurate read for heart health you can get and is only available in hospitals. This tech is in their own device that is currently being offered with their partner that has heart clinics in several states. More importantly, they have patents to make the tech work in smart watches and other devices. And their algorithm can easily be bought up by Apple or Samsung through acquisition. Do your own research, as far as positions I'm sitting on 5000 shares
ECG tracing on the charts.
Like a patient dying "ECG".
Fucking ECG ass port value over the last couple of weeks but still in profit which is all that matters
META ytd chart looks like an ECG. Patient is on life support
It was a joke about this talking point the 5 day looks like an ECG monitor
Is this a bear, bull, kangaroo or ECG market?
When your all time chart looks like an ECG after taking a mountain of coke to the dome.. That's options, baby!
stop looking at the ECG of a chart and go out and touch grass
this sounds like a solid move for both companies. the focus on atrial fibrillation is huge, especially with how many people are dealing with heart issues nowadays. I mean, the rise in mobile ECG adoption is kinda wild. if they can really make it more efficient and get those AI diagnostics rolling in Latin America, they could make a big impact. plus, starting in Chile makes sense since they can test the waters there before going bigger. curious how they’ll handle the regulatory stuff since that can be such a pain with these types of tech advancements. what do you think their biggest challenge will be?
Rubi's ECG looks bad. Were loosing him
Just looking at the 6M SPY chart you'd eyeball and say maybe another few days before the ECG like squiggle down, but I'm thinking maybe it starts tomorrow.
QQQ chart looks like an ECG. Heart attack soon?
**Bittium Oyj (BITTI.HE)** Europe has a rapidly growing need for European defence know-how and European-controlled technology. Recent geopolitical developments have made it very clear that critical military communications and defence systems cannot rely on non-European suppliers or fragile global supply chains. Strategic autonomy is no longer a political talking point. This is where Bittium fits extremely well. The company focuses on secure, military-grade communication systems developed and produced in Europe, specifically for European defence forces and government customers. For many countries, supplier origin is no longer about cost efficiency, but about trust, sovereignty, and long-term security of supply. Bittium is not just a hardware vendor. It provides complete end-to-end solutions: software-defined radios, tactical networks, encryption, and system integration. Once these systems are selected and deployed, customers are effectively locked in for many years — often decades — through upgrades, maintenance, and interoperability requirements. This creates high switching costs and strong competitive moats. As European defence spending increases and multiple countries modernise their tactical communication systems simultaneously, the demand for NATO-compatible, European-built solutions is accelerating. In this environment, Bittium is gaining traction fast and is on a clear path toward becoming a market leader in European tactical military communications, particularly for land forces. On top of defence, Bittium also has a medical segment focused on ECG and biosignal monitoring, which represents a second, highly interesting long-term growth story alongside defence.
NVDA 5 day chart looking like an ECG during a cardiac arrest
chart looks like ECG bouta flatline...
What the hell did you put it in? An ECG of a heart disease patient?
An echocardiogram is an ultrasound, you're thinking of an ECG/EKG for you dyslexic yanks.
I trimmed a little at 2.6 when i saw the market turning to secure some profits and get rid of my leveraged portion of the position. still holding the rest. I'll trim off the rest at $2 if it fails for less profits (in at 1.5 this morning) but i largely base my trims on the price action. Hoping for $3.5-$4 but largely dependent on buying volume. I was looking at the market just now for EKG demand and got this so far: # Launch Timeline & Market Revenue Heartbeam is currently a **pre-revenue company** focused on product rollout. Specific revenue estimates from the company are **not publically stated** at this time, but the plan is: * **Launch Target:** A **limited U.S. commercial launch** is planned for **Q1 2026** (early 2026). * **Initial Focus:** The launch will target select **concierge and preventive cardiology groups** who have already shown interest, establishing a high-value beachhead. * **Market Context:** They are entering a huge, growing market: * Global Mobile ECG Devices Market: **$4.53 Billion (2025)**, expected to reach **$8.89 Billion by 2032**. * Analyst sentiment is generally positive ("Buy" ratings), reflecting optimism about their disruptive technology in this multi-billion dollar space. # Heartbeam's Competitive Landscape Heartbeam's main advantage is the **12-lead synthesis**. This places them uniquely between simple consumer devices and complex hospital equipment. # 1. Direct At-Home Mobile ECG Competitors These devices are the most direct threat in terms of convenience and consumer adoption, but they lack the full 12-lead capability. * **AliveCor (KardiaMobile, 6L):** The market leader in personal ECG, offering up to **6-lead** recordings, but not a full 12-lead synthesis. * **iRhythm Technologies (Zio Patch):** Dominant in the **extended-wear/Holter monitor** market segment. * **Consumer Wearables (Apple Watch, Samsung):** Offer single-lead (I) rhythm checks, but minimal clinical diagnostic value compared to 12-lead. # 2. Traditional Medical Device Giants These giants own the existing clinical EKG market and could eventually develop competing technology. * **GE HealthCare (GEHC)** * **Koninklijke Philips N.V. (Philips Healthcare)** * **Abbott Laboratories** * **Medtronic plc** With a current market cap of 88m I think this stock will have a lot of room for growth, plan to hold 200 shares for the longer term
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment https://ca.finance.yahoo.com/news/heartbeam-receives-fda-clearance-first-120000188.html
BEAT. HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment
I can't tell if you are serious or not since you used the ... I mean the GE spin off have done extremely well lol. As an investor, it's a great idea, since it's easier to understand smaller businesses. I mean GEV spun off on April 2, 2024. It's only up 325% since that spin off. GE it's self is up like 100% since then. GEHC is the only one that hasn't done as well. However, there been a handful of other successful spin offs of recent. CARR, NXT, ECG are a few others than done well after spinning off.
DE has been on a solid run. A lot of the engineering names have also been killing it. AGX, FIX, IESC, ECG, PRIM have been crushing it.
So buy companies like ECG.
Not holding onto $ECG was a dumb move lol. Looks to be having a great day off their earnings report.
$ECG * Revenues of $986.8 million\*, up 29.7%. * Net income of $57.0 million\*, up 36.4%; net income margin of 5.8%. * Diluted earnings per share (EPS) of $1.11\*, up 35.4%. * Earnings before interest, taxes, depreciation and amortization (EBITDA) of $89.0 million\*, up 36.9%; EBITDA margin of 9.0%. * Backlog of $2.95 billion, up 6.0% from Dec. 31, 2024, and up 2.1% from Sept. 30, 2024. * Raises estimated full-year guidance for 2025: Revenues expected to be in the range of $3.55 billion to $3.65 billion and EBITDA expected to be in the range of $290 million to $300 million. “We maintained strong business momentum through the third quarter, delivering record revenue and EBITDA driven by excellent project execution and robust opportunities across our core end markets,” said Jeffrey S. Thiede, president and CEO of Everus. “Revenues increased 30%, with margin expansion in both our E&M and T&D segments, resulting in 37% EBITDA growth. Our E&M segment increased revenue by 43% and EBITDA by 64%, supported by continued strength in the data center submarket. “Backlog at Sept. 30 rose 2% year over year while we continued to deliver impressive revenue growth during the quarter. Bidding activity remains healthy, particularly across our commercial, industrial and utility markets, and we are confident in our ability to continue to win projects through our competitive advantages, longstanding customer relationships and favorable market tailwinds."
Brother that port is an ECG
Shit look like an ECG
1 month chart looking super healthy For an ECG
This looks like the ECG chart which you would get if you quit the job for trading.
Bitcoin chart a straight line like on ECG.
OP is a regard at this point. These guys have RS so much that their chart looks like freaking heart attack on an ECG.
Not that any data has logical relation to the indicators .. but yes throw some data and see the ECG graph fluctuate lol.
Having a good chunk of my port in OPEN makes life interesting. Seeing your life savings fluctuate like an ECG really spices it up 💀
META just unveiled their new Meta Glasses with AR vision and ECG band, alongside with the refresh for the rayban meta & a new oakley pair for athletes. very very bullish, they're at 777.77 rn in openmarket, pretty sure we'll see 800$ sooner than later.
Looks like an ECG just before someone dies
What are you even trading to see that consistent oscillation for a year straight, pull your profits when you were up and invest in something else that doesn’t look the ECG readout of someone with ventricular tachycardia 😭
Looks like ECG blood pressure. I assume the heart was working probably the same during the day
Going to try and grab a symphony position in PLPC after the ECG report.
Looks like a solid open for ECG from their earnings. MPTI numbers from yesterday. Revenue: in-line with est. EPS: missed ($0.53 vs. $0.60) Revenue: $13.3m (+13% YoY) Gross Margin: 43.6% (46.6% PY) EBITDA: $2.4mm (-4% YoY) EPS: $0.53 (-16% YoY) Backlog: $61.2mm (+35% vs. FY24)
Looks like a good report for $ECG! That reminded me to check on $NWPX and that has run up as well. Too bad I didn't buy back in there, but will keep an eye out for a pullback.
What of UNH was really denying too many claims over the years. Now, by attempting to approve more, they just never go back to their old earnings power? Also, took a starter in ECG. Missed the spin off dip, but still trading at half the P/S of comps. Hoping USLM falls a bit more, but we'll see. Definitely a great company at fair value right now. KFS rebounded back above $14, which is nice. Really looking to see where that goes on earnings next week.
I missed the spin off dip on it, but ECG also an interesting one to follow. They do a lot of work on electrical transmission lines so a slightly different angle then the others.
Sir, this is a CASINO. But yes, I've been looking at it daily since mango took office. It's been acting like broken ECG since he announced tariffs on penguins. What I really look at is the SOFR, which never failed to predict rate cuts. It's been soft for a week or so. We're definitely heading towards a recession, but shhhhh... you're killing the vibe !
|Area|Innovations/Highlights| |:-|:-| || || |Hardware|Apple Silicon, AirPods, Apple Watch, iPhone refinements| || || |New Categories|AirPods, Apple Watch, Vision Pro| || || |Services|TV+, Music, Pay, Arcade, Fitness+, Card| || || |Privacy & Security|App Tracking Transparency, on-device AI| || || |Health|ECG, fall detection, cycle tracking| || || |Ecosystem Strategy|Device-to-device integration, lock-in| || || |Sustainability|Recycled materials, carbon neutrality goals|
|Area|Innovations/Highlights| |:-|:-| || || |Hardware|Apple Silicon, AirPods, Apple Watch, iPhone refinements| || || |New Categories|AirPods, Apple Watch, Vision Pro| || || |Services|TV+, Music, Pay, Arcade, Fitness+, Card| || || |Privacy & Security|App Tracking Transparency, on-device AI| || || |Health|ECG, fall detection, cycle tracking| || || |Ecosystem Strategy|Device-to-device integration, lock-in| || || |Sustainability|Recycled materials, carbon neutrality goals|
|Area|Innovations/Highlights| |:-|:-| || || |Hardware|Apple Silicon, AirPods, Apple Watch, iPhone refinements| || || |New Categories|AirPods, Apple Watch, Vision Pro| || || |Services|TV+, Music, Pay, Arcade, Fitness+, Card| || || |Privacy & Security|App Tracking Transparency, on-device AI| || || |Health|ECG, fall detection, cycle tracking| || || |Ecosystem Strategy|Device-to-device integration, lock-in| || || |Sustainability|Recycled materials, carbon neutrality goals|
bro chart already look like 65 y/o ECG reading
$ECG spinoff doing well on earnings today
If you’re healthy and everything is fine, likely the EVG leads were place incorrectly when the incidental ECG was performed.
AAPL chart is literally an ECG
From GPT: That SPY chart kind of looks like the ECG of someone who’s been through an emotional rollercoaster — maybe a person watching their portfolio live on WallStreetBets. To put it in medical terms: • Starts with a regular rhythm (steady price action), • Then some arrhythmic bumps and dips (market jitters), • Followed by a full-on heart attack around April 4–8 (massive drop), • Then a few PVCs (premature ventricular contractions) — wild swings, • And finally a gradual recovery back to a more stable rhythm (a hopeful but cautious rise). Definitely not a healthy resting heart rate — more like someone chugging Red Bulls during market hours.
ECG chart here just like my heart
SPY is looking like an ECG, a flatline wouldn't be the worst thing lmao
EKG and ECG refer to the same test, known as an electrocardiogram, which measures the electrical activity of the heart. The term EKG comes from the German spelling, while ECG is the English abbreviation.
My ECG looking like SPY 💀
Markets looking like an ECG of someone overdosing on Fentynal
TSLA chart looks like an ECG of a wounded cop
Shit so silly it’s starting to look like an ECG
Your ECG as you go into vfib. 😵
Didn't someone mention wanting to get into $ECG after a selloff eventually happens? Looks like it just did. I'll need to look into it over the weekend and consider a position. Same with $ALSN
Innovation does not have to be fancy the end product. They have innovated plenty. Their M series chips blow everyone else out of the water. Their laptops are miles ahead of every competitor as a result. The $800 iPad powered by M series chips is more powerful than every windows laptop available under $2000. Designing such chips isn’t trivial. Qualcomm and AMD etc have been trying to compete for years and Apple keeps pulling ahead. They will launch an edge AI chip that will blow everyone out of the water too. Wait for it. They will be able to run AI models on the phone instead of cloud, making API calls basically free because your own phone hosts the models. And for a hardware company, apple’s software game is world class. Compare how good apple is with software to how good google is with hardware. You can even argue Apple being a hardware company created better software with ios than google, which is a software company, does with android. Apple Watches are the best in class, can have FDA approved features like blood oxygen, ECG, recently got approval for hypertension detection etc. All this is real innovation. Innovation need not be a new fancy product every time.
Meta is showing it is alive throwing ECG
Went to visit grandpa at the hospital. His ECG shows several pump and dumps 
The f in this world is an ECG